https://pharmoniq.com/news/fda-drug-repurposing-framework-public-input-2024 PharmoniQ en 2026-05-12T14:10:49.822Z FDA Seeks Public Input on Drug Repurposing Framework for Unmet Needs FDA, drug-repurposing, regulatory-policy, unmet-medical-needs, pharmaceutical-research https://pharmoniq.com/news/fda-approves-bizengri-nrg1-fusion-cholangiocarcinoma PharmoniQ en 2026-05-12T08:47:02.416Z FDA Approves Bizengri for Ultra-Rare Bile Duct Cancer Subtype FDA approval, cholangiocarcinoma, precision oncology, rare disease, biomarker therapy https://pharmoniq.com/news/pharmacy-quality-rewards-program-value-based-care-transformation PharmoniQ en 2026-05-11T14:10:49.048Z Pharmacy Quality Rewards Program Signals Major Shift to Value-Based Care value-based-care, pharmacy-reimbursement, quality-metrics, healthcare-policy, clinical-pharmacy